Close Menu

MTM Laboratories

Paired with Roche's HPV testing offerings, the deal will expand its cervical cancer testing capabilities.

The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.

The funds will be used to support clinical trials and commercialization efforts, as well as US regulatory clinical trials for a PMA submission for its CINtec Plus Cytology platform.

The CTAF recommendation is "an important decision-making resource for clinicians and patients," the firm's CEO said.

Patents awarded to GeneNews, US Army, Aisin Seiki, MTM Laboratories, and USC.

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

In an editorial at BMJ Opinion, two genetic counselors call for an increased focus on post-test patient care.

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.